Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02243020 · ClinicalTrials.gov registry record · NA
VNS During Rehabilitation for Improved Upper Limb Motor Function After Stroke
A NA study, sponsored by MicroTransponder.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT02243020 is a NA study that has completed, run by MicroTransponder. The registered enrollment target is 17 participants.
The verdict
NCT02243020, a NA study, has completed, sponsored by MicroTransponder.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
The primary study objectives are to assess the safety and feasibility of the therapy, including the surgical intervention and stimulation, as well as to provide information on the appropriateness of the study test measures (assessments) and to provide a basis for sample size calculations for a larger, pivotal study.
Interventions
- DEVICE Vagus Nerve Stimulation (VNS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2014-10 |
| Est. Completion | 2022-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02243020
The ClinicalTrials.gov registry entry for NCT02243020 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MicroTransponder, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Vagus Nerve Stimulation (VNS) is the first listed.
NCT02243020 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02243020 about?
NCT02243020 is a clinical study titled "VNS During Rehabilitation for Improved Upper Limb Motor Function After Stroke". The primary study objectives are to assess the safety and feasibility of the therapy, including the surgical intervention and stimulation, as well as to provide information on the appropriateness of the study test measures (assessments) and to provide a basis for sample size calculations for a large...
What is the current status of trial NCT02243020?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2014-10. Estimated completion is 2022-06-01.
What interventions are being tested in trial NCT02243020?
The interventions under investigation include: Vagus Nerve Stimulation (VNS) (DEVICE).
Who is sponsoring clinical trial NCT02243020?
This trial is sponsored by MicroTransponder, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.